These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30465490)

  • 21. Retinal measurements predict 10-year disability in multiple sclerosis.
    Rothman A; Murphy OC; Fitzgerald KC; Button J; Gordon-Lipkin E; Ratchford JN; Newsome SD; Mowry EM; Sotirchos ES; Syc-Mazurek SB; Nguyen J; Caldito NG; Balcer LJ; Frohman EM; Frohman TC; Reich DS; Crainiceanu C; Saidha S; Calabresi PA
    Ann Clin Transl Neurol; 2019 Feb; 6(2):222-232. PubMed ID: 30847355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dyschromatopsia in multiple sclerosis reflects diffuse chronic neurodegeneration beyond anatomical landmarks.
    Barreiro-González A; Sanz MT; Carratalà-Boscà S; Pérez-Miralles F; Alcalá C; España-Gregori E; Casanova B
    Acta Neurol Belg; 2021 Dec; 121(6):1767-1775. PubMed ID: 33044738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical coherence tomography detection of neurodegeneration in multiple sclerosis.
    Lidster K; Baker D
    CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):518-27. PubMed ID: 22583437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered birefringence of peripapillary retinal nerve fiber layer in multiple sclerosis measured by polarization sensitive optical coherence tomography.
    Jiang H; Chen W; Delgado S; Liu Y; Lin Y; Wang J
    Eye Vis (Lond); 2018; 5():14. PubMed ID: 29951559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First measured retinal nerve fiber layer thickness in RRMS can be used as a biomarker for the course of the disease: threshold value discussions.
    Cilingir V; Batur M
    J Neurol; 2021 Aug; 268(8):2858-2865. PubMed ID: 33606071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olfactory dysfunction in multiple sclerosis: evidence of a decrease in different aspects of olfactory function.
    Rolet A; Magnin E; Millot JL; Berger E; Vidal C; Sileman G; Rumbach L
    Eur Neurol; 2013; 69(3):166-70. PubMed ID: 23257936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olfactory dysfunction as a prognostic marker for disability progression in Multiple Sclerosis: An olfactory event related potential study.
    Ciurleo R; Bonanno L; De Salvo S; Romeo L; Rifici C; Sessa E; D'Aleo G; Russo M; Bramanti P; Marino S; Caminiti F
    PLoS One; 2018; 13(4):e0196006. PubMed ID: 29664936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olfactory dysfunction in multiple sclerosis.
    Atalar AÇ; Erdal Y; Tekin B; Yıldız M; Akdoğan Ö; Emre U
    Mult Scler Relat Disord; 2018 Apr; 21():92-96. PubMed ID: 29529530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Retinal Layer Thickness Parameters as Biomarkers in a Real-World Multiple Sclerosis Cohort.
    Schurz N; Sariaslani L; Altmann P; Leutmezer F; Mitsch C; Pemp B; Rommer P; Zrzavy T; Berger T; Bsteh G
    Eye Brain; 2021; 13():59-69. PubMed ID: 33737853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normative data for the "Sniffin' Sticks" including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects.
    Hummel T; Kobal G; Gudziol H; Mackay-Sim A
    Eur Arch Otorhinolaryngol; 2007 Mar; 264(3):237-43. PubMed ID: 17021776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
    Zaveri MS; Conger A; Salter A; Frohman TC; Galetta SL; Markowitz CE; Jacobs DA; Cutter GR; Ying GS; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2008 Jul; 65(7):924-8. PubMed ID: 18625859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers.
    Novakova L; Axelsson M; Malmeström C; Imberg H; Elias O; Zetterberg H; Nerman O; Lycke J
    PLoS One; 2018; 13(4):e0194828. PubMed ID: 29614113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Swept-Source Optical Coherence Tomography Thresholds in Differentiating Clinical Outcomes in a Real-World Cohort of Treatment-Naïve Multiple Sclerosis Patients.
    Rzepiński Ł; Kucharczuk J; Tkaczyńska M; Parisi V; Grzybowski A
    Brain Sci; 2023 Mar; 13(4):. PubMed ID: 37190556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinal Nerve Fiber Layer Thickness Correlates with Serum and Cerebrospinal Fluid Neurofilament Levels and is Associated with Current Disability in Multiple Sclerosis.
    Uzunköprü C; Yüceyar N; Yilmaz SG; Afrashi F; Ekmekçi Ö; Taşkiran D
    Noro Psikiyatr Ars; 2021 Mar; 58(1):34-40. PubMed ID: 33795950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
    Yaldizli Ö; Penner IK; Yonekawa T; Naegelin Y; Kuhle J; Pardini M; Chard DT; Stippich C; Kira JI; Bendfeldt K; Amann M; Radue EW; Kappos L; Sprenger T
    Eur J Neurol; 2016 Mar; 23(3):510-9. PubMed ID: 26699999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.
    Balk LJ; Cruz-Herranz A; Albrecht P; Arnow S; Gelfand JM; Tewarie P; Killestein J; Uitdehaag BM; Petzold A; Green AJ
    J Neurol; 2016 Jul; 263(7):1323-31. PubMed ID: 27142714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sniffin' Sticks and olfactory system imaging in patients with Kallmann syndrome.
    Ottaviano G; Cantone E; D'Errico A; Salvalaggio A; Citton V; Scarpa B; Favaro A; Sinisi AA; Liuzzi R; Bonanni G; Di Salle F; Elefante A; Manara R; Staffieri A; Martini A; Brunetti A
    Int Forum Allergy Rhinol; 2015 Sep; 5(9):855-61. PubMed ID: 25951300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Findings of Optical Coherence Tomography of Retinal Nerve Fiber Layer in Two Common Types of Multiple Sclerosis.
    Yousefipour G; Hashemzahi Z; Yasemi M; Jahani P
    Acta Med Iran; 2016 Jun; 54(6):382-90. PubMed ID: 27306345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of cognition, quality of life, and fatigue on olfactory function in patients with multiple sclerosis.
    Acikgoz M; Piri Cinar B; Aciman Demirel E; Celebi U; Cekic S; Elicora S; Atasoy HT
    Clin Neurol Neurosurg; 2023 Jun; 229():107739. PubMed ID: 37146370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unilateral olfactory sensitivity in multiple sclerosis.
    Good KP; Tourbier IA; Moberg P; Cuzzocreo JL; Geckle RJ; Yousem DM; Pham DL; Doty RL
    Physiol Behav; 2017 Jan; 168():24-30. PubMed ID: 27780720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.